Table 3.
fNIRS data for ROI analysis.
| (a) Means and standard deviations | ||||||||
|---|---|---|---|---|---|---|---|---|
| GXR-to-placebo (n = 4) | placebo-to-GXR (n = 7) | |||||||
| intra-GXR | intra-placebo | intra-GXR | intra-placebo | |||||
| M | SD | M | SD | M | SD | M | SD | |
| CH10 Δoxy-Hb (mM·mm) | −0.01 | 0.05 | 0.04 | 0.06 | 0.05 | 0.06 | 0.01 | 0.08 |
| (b) Two-way mixed ANCOVA for medication type and medication order | ||||||||
| Source | df 1 , df 2 | F | p | ES | ||||
| Main effect of medication type (intra-GXR vs. intra-placebo) | 1, 8 | 0.010 | 0.923 | 0.001 | ||||
| Main effect of medication order (GXR-to-placebo vs. placebo-to-GXR) | 1, 8 | 0.197 | 0.669 | 0.024 | ||||
| Interaction of medication type and age in months | 1, 8 | 0.006 | 0.938 | 0.001 | ||||
M, mean; SD, standard deviation; df1, degrees of freedom 1; df2, degrees of freedom 2; F, F-value; p, p-value; ES, effect size.